香港股市 將收市,收市時間:1 小時 38 分鐘

Bayer Aktiengesellschaft (BAYRY)

Other OTC - Other OTC 延遲價格。貨幣為 USD。
加入追蹤清單
7.60+0.24 (+3.26%)
收市:03:59PM EDT

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
https://www.bayer.com

版塊Healthcare
行業Drug Manufacturers - General
全職員工96,931

高階主管

名稱頭銜支付行使價出生年份
Mr. William N. AndersonChairman of the Management Board & CEO9.03M1966
Mr. Wolfgang U. NicklCFO & Member of Management Board2.12M1969
Mr. Heiko W. J. SchipperMember of Management Board & President of the Consumer Health Division2.08M1969
Mr. Stefan OelrichHead of the Pharmaceuticals Division & Member of the Board of Management2.09M1968
Mr. Rodrigo SantosMember of Management Board & President of the Crop Science Division2.32M1973
Ms. Heike PrinzChief Talent Officer, Labor Director & Member of Management Board1.42M1964
Mr. Julio TrianaMember of Management Board & President of Consumer Health Division1966
Dr. Sebastian Guth Ph.D.Chief Operating Officer
Dr. Jost ReinhardHead of Investor Relations1972
Mr. Michael PreussHead of Communications, Government Relations and Corporate Brand
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

公司管治

截至 2024年5月1日 止,Bayer Aktiengesellschaft 的 ISS 管治質素評分為 3。 Pillar 分數正在審核中:10;董事會:2;股東權利:1;現金賠償:2。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。